Skip to search formSkip to main contentSkip to account menu

response to paclitaxel

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Background: Kaposiform hemangioendothelioma (KHE) is a rare neoplasm of vascular origin that typically arises from the skin or… 
2015
2015
This study describes a system for quantifying paclitaxel activity using the C-terminus of α-tubulin as a biomarker. Following… 
2014
2014
Metastatic Rhabdoid Melanoma of Parotid Gland: Remarkable Response to Paclitaxel/Carboplatin Combination Melanoma with rhabdoid… 
Review
2013
Review
2013
...................................................................................................................................... i Dedication .................................................................................................................................. ii Table of contents ...................................................................................................................... iii List of figures ............................................................................................................................. v Acknowledgements ................................................................................................................... vi List of abbreviations ................................................................................................................ vii Chapter 1: Introduction .............................................................................................................. 1 1.1 Cancer: an overview ......................................................................................................... 1 1.1.1 Ovarian cancer ........................................................................................................... 1 1.1.2 Colorectal Cancer ...................................................................................................... 2 1.2 WWOX: a bona fide tumour suppressor gene ................................................................ 2 1.2.1 The role of WWOX in ovarian cancer ....................................................................... 3 1.3 The endoplasmic reticulum and ER stress ....................................................................... 3 1.4 ER stress and the unfolded protein response .................................................................... 4 1.4.1 Mechanism of the UPR.............................................................................................. 4 1.4.2 The apoptotic arm of the UPR ................................................................................... 6 1.5 The UPR and cancer development ................................................................................... 7 1.6 ER stress and chemotherapy ............................................................................................ 8 1.6.1 Paclitaxel ................................................................................................................... 8 1.7 Aims ................................................................................................................................. 9 1.7.1 Targeting ER stress in order to inhibit paclitaxel chemotherapy response ............... 9 1.7.2 Characterizing the activation of ER stress by paclitaxel in different cancer cell lines ............................................................................................................................................ 9 Chapter 2: Materials and methods ........................................................................................... 11 2.1 Cell culture ..................................................................................................................... 11 2.1.1 Basic maintenance of cell lines ............................................................................... 11 2.1.2 Passaging of cell lines .............................................................................................. 11 2.1.3 Freezing and recovery of cell lines .......................................................................... 11 2.2 Cell survival assays ........................................................................................................ 11 
2010
2010
Purpose: Triple negative breast cancer (TNBC) has had poor prognosis compared with the luminal subtype. And there has been no… 
2009
2009
Abstract: The present study is aimed to examine the possible effects of Protein Malnutrition (PM) on the therapeutic activity and… 
2009
2009
CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts Abstract #6065 Background: Increased CDK1 activity and reduced… 
2005
2005
Background and Objectives:The local delivery of drugs to the arterial wall represents a strategy for the treatment of… 
2000
2000
The purpose of this study was to retrospectively predict the chemotherapy response to paclitaxel in non-small cell lung cancer… 
1997
1997
We studied the combination of tumor necrosis factor (TNF) and paclitaxel. Our aim was to determine whether TNF increases the…